Polymorphism in the Microglial Cell-Mobilizing CX3CR1 Gene Is Associated With Survival in Patients With Glioblastoma
Author(s) -
Mathieu P. Rodero,
Yannick Marie,
Mathieu Coudert,
Emmeline Blondet,
Karima Mokhtari,
Audrey Rousseau,
William Raoul,
Alain Carpentier,
Florian Sennlaub,
Philippe Déterre,
JeanYves Delattre,
Patrice Debré,
Marc Sanson,
Christophe Combadière
Publication year - 2008
Publication title -
journal of clinical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 10.482
H-Index - 548
eISSN - 1527-7755
pISSN - 0732-183X
DOI - 10.1200/jco.2008.17.2833
Subject(s) - medicine , glioblastoma , gene , cx3cr1 , microglia , cancer research , oncology , chemokine , genetics , inflammation , biology , chemokine receptor
Few reliable prognostic molecular markers have been characterized for glioblastoma multiforme (GBM), considered the deadliest of human cancers. We hypothesized that genetic polymorphisms in chemokines and their receptors, which together control microglial cell mobilization, may influence survival.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom